Non-Small Cell Lung Cancer — Targeting KRAS G12C

Featuring perspectives from Prof Solange Peters and Dr Joshua K Sabari, including the following topics:

Introduction (0:00)Best Option for Your Patient (1:28)Biological Considerations (6:26)KRAS G12C Inhibitors (11:33)Second-Line Treatment (13:02)Current Clinical Trials in the First-Line Metastatic Setting (32:18)Current Clinical Trials in the Localized Setting (49:52)Current Clinical Trials with New Treatment Combinations and Agents (53:51)

CME information and select publications